Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response

  1. Carmela Sidrauski  Is a corresponding author
  2. Jordan C Tsai
  3. Martin Kampmann
  4. Brian R Hearn
  5. Punitha Vedantham
  6. Priyadarshini Jaishankar
  7. Masaaki Sokabe
  8. Aaron S Mendez
  9. Billy W Newton
  10. Edward L Tang
  11. Erik Verschueren
  12. Jeffrey R Johnson
  13. Nevan J Krogan
  14. Christopher S Fraser
  15. Jonathan S Weissman
  16. Adam R Renslo
  17. Peter Walter
  1. University of California, San Francisco, United States
  2. Howard Hughes Medical Institution, University of California, San Francisco, United States
  3. University of California, Davis, United States

Abstract

The general translation initiation factor eIF2 is a major translational control point. Multiple signaling pathways in the integrated stress response phosphorylate eIF2 serine-51, inhibiting nucleotide exchange by eIF2B. ISRIB, a potent drug-like small molecule, renders cells insensitive to eIF2α phosphorylation and enhances cognitive function in rodents by blocking long-term depression. ISRIB was identified in a phenotypic cell-based screen, and its mechanism of action remained unknown. We now report that ISRIB is an activator of eIF2B. Our reporter-based shRNA screen revealed an eIF2B requirement for ISRIB activity. Our results define ISRIB as a symmetric molecule, show ISRIB-mediated stabilization of activated eIF2B dimers, and suggest that eIF2B4 (δ-subunit) contributes to the ISRIB binding site. We also developed new ISRIB analogs, improving its EC50 to 600 pM in cell culture. By modulating eIF2B function, ISRIB promises to be an invaluable tool in proof-of-principle studies aiming to ameliorate cognitive defects resulting from neurodegenerative diseases.

Article and author information

Author details

  1. Carmela Sidrauski

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    For correspondence
    carmelas@me.com
    Competing interests
    CS: Inventors on UC patent application PCT/US2014/029568. Title: Modulators of the eIF2a pathway.
  2. Jordan C Tsai

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5202-722X
  3. Martin Kampmann

    Howard Hughes Medical Institution, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3819-7019
  4. Brian R Hearn

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Competing interests
    BRH: Inventors on UC patent application PCT/US2014/029568. Title: Modulators of the eIF2a pathway.
  5. Punitha Vedantham

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Competing interests
    PV: Inventors on UC patent application PCT/US2014/029568. Title: Modulators of the eIF2a pathway.
  6. Priyadarshini Jaishankar

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  7. Masaaki Sokabe

    Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  8. Aaron S Mendez

    Howard Hughes Medical Institution, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  9. Billy W Newton

    QB3, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  10. Edward L Tang

    QB3, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  11. Erik Verschueren

    QB3, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5842-6344
  12. Jeffrey R Johnson

    QB3, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  13. Nevan J Krogan

    QB3, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  14. Christopher S Fraser

    Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  15. Jonathan S Weissman

    Howard Hughes Medical Institution, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  16. Adam R Renslo

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Competing interests
    ARR: Inventors on UC patent application PCT/US2014/029568. Title: Modulators of the eIF2a pathway.
  17. Peter Walter

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    PW: Inventors on UC patent application PCT/US2014/029568. Title: Modulators of the eIF2a pathway.

Funding

Howard Hughes Medical Institute (HHMI)

  • Carmela Sidrauski
  • Jordan C Tsai
  • Martin Kampmann
  • Aaron S Mendez
  • Jonathan S Weissman
  • Peter Walter

The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2015, Sidrauski et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,141
    views
  • 2,091
    downloads
  • 217
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Carmela Sidrauski
  2. Jordan C Tsai
  3. Martin Kampmann
  4. Brian R Hearn
  5. Punitha Vedantham
  6. Priyadarshini Jaishankar
  7. Masaaki Sokabe
  8. Aaron S Mendez
  9. Billy W Newton
  10. Edward L Tang
  11. Erik Verschueren
  12. Jeffrey R Johnson
  13. Nevan J Krogan
  14. Christopher S Fraser
  15. Jonathan S Weissman
  16. Adam R Renslo
  17. Peter Walter
(2015)
Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response
eLife 4:e07314.
https://doi.org/10.7554/eLife.07314

Share this article

https://doi.org/10.7554/eLife.07314

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Mai Nguyen, Elda Bauda ... Cecile Morlot
    Research Article

    Teichoic acids (TA) are linear phospho-saccharidic polymers and important constituents of the cell envelope of Gram-positive bacteria, either bound to the peptidoglycan as wall teichoic acids (WTA) or to the membrane as lipoteichoic acids (LTA). The composition of TA varies greatly but the presence of both WTA and LTA is highly conserved, hinting at an underlying fundamental function that is distinct from their specific roles in diverse organisms. We report the observation of a periplasmic space in Streptococcus pneumoniae by cryo-electron microscopy of vitreous sections. The thickness and appearance of this region change upon deletion of genes involved in the attachment of TA, supporting their role in the maintenance of a periplasmic space in Gram-positive bacteria as a possible universal function. Consequences of these mutations were further examined by super-resolved microscopy, following metabolic labeling and fluorophore coupling by click chemistry. This novel labeling method also enabled in-gel analysis of cell fractions. With this approach, we were able to titrate the actual amount of TA per cell and to determine the ratio of WTA to LTA. In addition, we followed the change of TA length during growth phases, and discovered that a mutant devoid of LTA accumulates the membrane-bound polymerized TA precursor.

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    Shinichi Kawaguchi, Xin Xu ... Toshie Kai
    Research Article

    Protein–protein interactions are fundamental to understanding the molecular functions and regulation of proteins. Despite the availability of extensive databases, many interactions remain uncharacterized due to the labor-intensive nature of experimental validation. In this study, we utilized the AlphaFold2 program to predict interactions among proteins localized in the nuage, a germline-specific non-membrane organelle essential for piRNA biogenesis in Drosophila. We screened 20 nuage proteins for 1:1 interactions and predicted dimer structures. Among these, five represented novel interaction candidates. Three pairs, including Spn-E_Squ, were verified by co-immunoprecipitation. Disruption of the salt bridges at the Spn-E_Squ interface confirmed their functional importance, underscoring the predictive model’s accuracy. We extended our analysis to include interactions between three representative nuage components—Vas, Squ, and Tej—and approximately 430 oogenesis-related proteins. Co-immunoprecipitation verified interactions for three pairs: Mei-W68_Squ, CSN3_Squ, and Pka-C1_Tej. Furthermore, we screened the majority of Drosophila proteins (~12,000) for potential interaction with the Piwi protein, a central player in the piRNA pathway, identifying 164 pairs as potential binding partners. This in silico approach not only efficiently identifies potential interaction partners but also significantly bridges the gap by facilitating the integration of bioinformatics and experimental biology.